The Europe Multiple Sclerosis Treatment market was valued at USD 6,026.70 Million in 2022 and is expected to reach USD 10,201.16 Million by 2030, growing at a CAGR of 6.8% (2022-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.